EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)

Ning Jin, Yu Xia, Qinglei Gao

International Journal of Oncology · 2023

DOI: 10.3892/ijo.2023.5476 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Ning Jin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of The Ministry of Education, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science …. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the development of precision medicine, targeted therapy has attracted extensive attention. Poly(ADP‑ribose) polymerase inhibitors (PARPi) are critical clinical drugs designed to induce cell death and are major antitumor targeted agents. However, preclinical and clinical data have revealed the limitations of PARPi monotherapy. Therefore, their combination with other targeted drugs has become a research hotspot in tumor treatment. Recent studies have demonstrated the critical role of small molecular inhibitors in multiple haematological cancers and solid tumors via cellular signalling modulation, exhibiting potential as a combined pharmacotherapy. In the present review, studies focused on small molecular inhibitors targeting the homologous recombination pathway were summarized and clinical trials evaluating the safety and efficacy of combined treatment were discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansPoly(ADP-ribose) Polymerase InhibitorsCombined Modality TherapyPrecision Medicine

Stichwörter der Autor:innen

DNA damage responsePARP inhibitorsclinical trialscombination therapysmall molecular inhibitors

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of The Ministry of Education, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, P.R. China.

Zitieren

APA

Jin, N., Xia, Y., & Gao, Q. (2023). Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5476

Vancouver

Jin N, Xia Y, Gao Q. Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review). International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5476

BibTeX
@article{Jin2023,
  author = {Jin, Ning and Xia, Yu and Gao, Qinglei},
  title = {Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)},
  journal = {International Journal of Oncology},
  year = {2023},
  doi = {10.3892/ijo.2023.5476}
}
Kostenlos starten →